Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15839 | 28687713 | Clin Sci (Lond) | TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival. | 2017 | Details |
| A15840 | 28687459 | Drug Discov Today | Mouse models of nonalcoholic steatohepatitis in preclinical drug development. | 2017 | Details |
| A15841 | 28686633 | PLoS One | Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation. | 2017 | Details |
| A15842 | 28686624 | PLoS One | Adverse effects of chronic exposure to nonylphenol on non-alcoholic fatty liver disease in male rats. | 2017 | Details |
| A15843 | 28686220 | Children (Basel) | The Association between Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk in Children. | 2017 | Details |
| A15844 | 28685692 | Curr Top Med Chem | Molecular Determinants of Chronic Liver Disease as Studied by NMR-Metabolomics. | 2017 | Details |
| A15845 | 28685623 | Expert Opin Pharmacother | Cardiovascular disease prevention strategies for type 2 diabetes mellitus. | 2017 | Details |
| A15846 | 28685131 | Can J Gastroenterol Hepatol | Relationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity. | 2017 | Details |
| A15847 | 28684781 | Sci Rep | Characterization of transcriptional modules related to fibrosing-NAFLD progression. | 2017 | Details |
| A15848 | 28683306 | Cell Rep | RORα Induces KLF4-Mediated M2 Polarization in the Liver Macrophages that Protect against Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15849 | 28683283 | Cell Metab | Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes. | 2017 | Details |
| A15850 | 28681988 | Diabetes Obes Metab | Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial. | 2017 | Details |
| A15851 | 28680813 | FEBS Open Bio | Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease. | 2017 | Details |
| A15852 | 28680417 | Front Endocrinol (Lausanne) | Alternative RNA Splicing in the Pathogenesis of Liver Disease. | 2017 | Details |
| A15853 | 28680292 | Curr Oncol | Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases. | 2017 | Details |
| A15854 | 28680048 | Sci Rep | Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults. | 2017 | Details |
| A15855 | 28679676 | BMJ Open | Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study. | 2017 | Details |
| A15856 | 28679028 | Liver Int | Hepatic iron is the major determinant of serum ferritin in NAFLD patients. | 2017 | Details |
| A15857 | 28678821 | PLoS One | A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice. | 2017 | Details |
| A15858 | 28678410 | NMR Biomed | Simultaneous MR quantification of hepatic fat content, fatty acid composition, transverse relaxation time and magnetic susceptibility for the diagnosis of non-alcoholic steatohepatitis. | 2017 | Details |
| A15859 | 28678199 | Int J Mol Sci | The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. | 2017 | Details |
| A15860 | 28677866 | J Appl Toxicol | Increased incidence of non-alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis. | 2017 | Details |
| A15861 | 28677739 | Mol Med Rep | Protein profiling and functional analysis of liver mitochondria from rats with nonalcoholic steatohepatitis. | 2017 | Details |
| A15862 | 28677333 | Aliment Pharmacol Ther | Review article: new treatments in non-alcoholic fatty liver disease. | 2017 | Details |
| A15864 | 28677271 | Cancer Med | Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A15865 | 28676973 | Eur J Nutr | Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats. | 2017 | Details |
| A15867 | 28676836 | Oxid Med Cell Longev | Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH. | 2017 | Details |
| A15868 | 28676747 | Front Hum Neurosci | Inflammation: The Common Pathway of Stress-Related Diseases. | 2017 | Details |
| A15870 | 28676332 | Respir Physiol Neurobiol | Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity. | 2017 | Details |
| A15871 | 28676027 | Curr Vasc Pharmacol | The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options? | 2018 | Details |
| A15872 | 28676026 | Curr Vasc Pharmacol | A Critical Approach of Guideline Therapeutic Recommendations for NAFLD. | 2018 | Details |
| A15873 | 28676025 | Curr Vasc Pharmacol | Nonalcoholic Fatty Liver Disease vs. Nonalcoholic Steatohepatitis: Pathological and Clinical Implications. | 2018 | Details |
| A15874 | 28676024 | Curr Vasc Pharmacol | NAFLD-NASH: An Under-Recognized Epidemic. | 2018 | Details |
| A15875 | 28676020 | Curr Vasc Pharmacol | Current and Potential Future Pharmacological Approaches for Non- Alcoholic Fatty Liver Disease. | 2018 | Details |
| A15876 | 28676019 | Curr Vasc Pharmacol | Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk. | 2018 | Details |
| A15877 | 28676018 | Curr Vasc Pharmacol | Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease? | 2018 | Details |
| A15878 | 28674631 | Open Heart | Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure. | 2017 | Details |
| A15879 | 28674415 | Sci Rep | MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. | 2017 | Details |
| A15880 | 28674352 | Intern Med | A Customized Online Nutrition Guidance System Is Effective for Treating Patients with Nonalcoholic Fatty Liver Disease by Supporting Continuity of Diet Therapy at Home: A Pilot Study. | 2017 | Details |
| A15881 | 28673968 | Proc Natl Acad Sci U S A | Hepatic ZIP14-mediated zinc transport is required for adaptation to endoplasmic reticulum stress. | 2017 | Details |
| A15882 | 28673684 | Toxicol Appl Pharmacol | The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis. | 2017 | Details |
| A15883 | 28673635 | J Pharmacol Sci | Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet. | 2017 | Details |
| A15884 | 28673574 | Med Hypotheses | LDL-C levels in older people: Cholesterol homeostasis and the free radical theory of ageing converge. | 2017 | Details |
| A15886 | 28670854 | J Gastroenterol Hepatol | Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ. | 2018 | Details |
| A15888 | 28670394 | Am J Transl Res | PFP alleviates nonalcoholic steatohepatitis fatty liver in both Apo E-/- mice and Changliver cell[S]. | 2017 | Details |
| A15889 | 28669329 | Curr Vasc Pharmacol | Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension. | 2018 | Details |
| A15890 | 28669328 | Curr Vasc Pharmacol | Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome? | 2018 | Details |
| A15891 | 28667907 | Redox Biol | Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers. | 2017 | Details |
| A15892 | 28667519 | Sci China Life Sci | Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1. | 2017 | Details |
| A15893 | 28667176 | J Mol Endocrinol | miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1. | 2017 | Details |
| A15894 | 28666456 | Lipids Health Dis | Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study. | 2017 | Details |
| A15895 | 28665956 | PLoS One | Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians. | 2017 | Details |
| A15896 | 28665032 | Hepatology | Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents. | 2017 | Details |
| A15897 | 28664744 | Bratisl Lek Listy | Therapeutic effects of melatonin and quercetin in improvement of hepatic steatosis in rats through supression of oxidative damage. | 2017 | Details |
| A15898 | 28663676 | J Clin Exp Hepatol | Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? | 2017 | Details |
| A15899 | 28662945 | J Pediatr | Nonalcoholic Fatty Liver Disease in Italian Children with Down Syndrome: Prevalence and Correlation with Obesity-Related Features. | 2017 | Details |
| A15900 | 28662136 | PLoS One | Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats. | 2017 | Details |
| A15901 | 28660493 | Diabetologia | Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study. | 2017 | Details |
| A15902 | 28660151 | J Clin Transl Hepatol | Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis. | 2017 | Details |
| A15903 | 28660148 | J Clin Transl Hepatol | Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15904 | 28659437 | Sci Transl Med | Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β. | 2017 | Details |
| A15905 | 28658824 | J Clin Diagn Res | Prevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus. | 2017 | Details |
| A15906 | 28658094 | Medicine (Baltimore) | Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management. | 2017 | Details |
| A15908 | 28657604 | Nutrients | Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction. | 2017 | Details |
| A15909 | 28655985 | Ann Gastroenterol | Circulating adipokines in children with nonalcoholic fatty liver disease: possible noninvasive diagnostic markers. | 2017 | Details |
| A15911 | 28655714 | Am J Physiol Endocrinol Metab | Epidermal growth factor receptor restoration rescues the fatty liver regeneration in mice. | 2017 | Details |
| A15912 | 28655690 | Pak J Pharm Sci | Metformin HCl has curative effect on rebuilding of ventricular diastolic functions in high-fat-diet fed rats. | 2017 | Details |
| A15914 | 28655068 | Z Gastroenterol | Potential impact of screening for fatty liver disease by transient elastography with liver stiffness and controlled attenuation parameter measurements: a pilot study. | 2017 | Details |
| A15915 | 28654793 | Biomed Pharmacother | Pure total flavonoids from citrus improve non-alcoholic fatty liver disease by regulating TLR/CCL signaling pathway: A preliminary high-throughput 'omics' study. | 2017 | Details |
| A15917 | 28652891 | World J Hepatol | Non-alcoholic fatty liver disease: An expanded review. | 2017 | Details |
| A15918 | 28652750 | Neuropsychiatr Dis Treat | The prevalence and risk factors of young male schizophrenics with non-alcoholic fatty liver disease. | 2017 | Details |
| A15919 | 28652657 | World J Gastroenterol | Association of keratin 8/18 variants with non-alcoholic fatty liver disease and insulin resistance in Chinese patients: A case-control study. | 2017 | Details |
| A15920 | 28652650 | World J Gastroenterol | Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. | 2017 | Details |
| A15921 | 28652427 | In Vivo | A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells. | 2018 | Details |
| A15922 | 28651300 | Gut Liver | Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15923 | 28650518 | Liver Int | A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects. | 2017 | Details |
| A15924 | 28650209 | Expert Rev Gastroenterol Hepatol | The intestinal barrier: a fundamental role in health and disease. | 2017 | Details |
| A15925 | 28648927 | J Ethnopharmacol | Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation. | 2017 | Details |
| A15926 | 28647765 | Abdom Radiol (NY) | Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. | 2018 | Details |
| A15927 | 28647361 | Biochem Biophys Res Commun | Apolipoprotein O expression in mouse liver enhances hepatic lipid accumulation by impairing mitochondrial function. | 2017 | Details |
| A15929 | 28647324 | Trends Endocrinol Metab | AMPK as a Therapeutic Target for Treating Metabolic Diseases. | 2017 | Details |
| A15930 | 28647291 | Clin Nutr | Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial. | 2017 | Details |
| A15931 | 28646856 | BMC Immunol | The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice. | 2017 | Details |
| A15933 | 28646531 | Br J Pharmacol | Morin, a novel liver X receptor α/β dual antagonist, has potent therapeutic efficacy for nonalcoholic fatty liver diseases. | 2017 | Details |
| A15934 | 28645738 | J Hepatol | Human germline hedgehog pathway mutations predispose to fatty liver. | 2017 | Details |
| A15935 | 28644356 | J Pediatr Gastroenterol Nutr | Low Hepatic Tissue Copper in Pediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15936 | 28644089 | J Avian Med Surg | Evaluation of High Dosages of Oral Meloxicam in American Kestrels ( Falco sparverius ). | 2017 | Details |
| A15937 | 28643888 | Mol Nutr Food Res | Combination of citrus polymethoxyflavones, green tea polyphenols, and Lychee extracts suppresses obesity and hepatic steatosis in high-fat diet induced obese mice. | 2017 | Details |
| A15938 | 28643267 | Protein Cell | New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). | 2017 | Details |
| A15940 | 28642059 | J Hepatol | New trends on obesity and NAFLD in Asia. | 2017 | Details |
| A15941 | 28642009 | Toxicol Lett | Mice in the early stage of liver steatosis caused by a high fat diet are resistant to thioacetamide-induced hepatotoxicity and oxidative stress. | 2017 | Details |
| A15942 | 28641788 | Metabolism | Non-alcoholic fatty liver disease: A sign of systemic disease. | 2017 | Details |
| A15943 | 28641784 | Metabolism | Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases. | 2017 | Details |
| A15944 | 28641782 | Metabolism | High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study. | 2017 | Details |
| A15945 | 28641570 | Endocr Metab Immune Disord Drug Targets | 1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity. | 2017 | Details |
| A15946 | 28641031 | Expert Opin Drug Saf | Treatment options for nonalcoholic steatohepatitis - a safety evaluation. | 2017 | Details |
| A15947 | 28640662 | Gut Microbes | Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. | 2017 | Details |
| A15948 | 28640517 | Liver Int | Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy. | 2017 | Details |
| A15949 | 28640216 | Nutrients | A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15950 | 28639970 | Eur J Gastroenterol Hepatol | Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2017 | Details |